Zimerman A, Gaba P, O'Donoghue ML, Giugliano RP, Murphy SA, Ran X, Kuder JF, Ceska R, De Ferrari GM, Ferreira J, Gaciong ZA, Lopez-Sendon J, Lorenzatti A, Saraiva JFK, Jukema JW, Monsalvo ML, Flores-Arredondo JH, Atar D, Keech AC, Sabatine MS, Marston NA, Bergmark BA (2026)
Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE
Circulation, 153 (19), 1516-1519
DOI 10.1161/CIRCULATIONAHA.125.077140, PubMed 42113916

Dal-Re R, Abreu A, Biering-Sørensen T, Gale CP, Halvorsen S, Holm S, Ibanez B, James S, Latini R, Shaw D (2026)
Equity and representativeness in pragmatic drug trials: methodological and ethical considerations
BMJ Evid Based Med (in press)
DOI 10.1136/bmjebm-2025-114106, PubMed 42031521

Novo G, Lopez-Fernandez T, Delgado V, Lancellotti P, Almeida AG, Berger-Klein J, Celutkiene J, Dweck MR, Guglielmo M, Gulati G, Mirsadraee S, Nazir MS, Lyon AR, Stankovic I (2026)
Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments. A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC
Eur Heart J Cardiovasc Imaging (in press)
DOI 10.1093/ehjci/jeag103, PubMed 42025328